GVHD

Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.

Authors: Choi SW, Errickson J, Gatza E, Hoodin F, Kentor R, LaLonde L, Reddy P, Votruba K

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow

Myeloablative conditioning allogeneic hematopoietic cell transplantation (HCT) puts patients at greater risk for significant cognitive and quality of life decline compared with recipients of reduced-intensity conditioning or autologous HCT. Vorinostat, a histone deacetylase inhibitor, has been […]

Back to Publications